Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | PNAS
Core type 1 interferon (IFN-1)-associated genes are more highly... | Download Scientific Diagram
How cancer cells make and respond to interferon-I: Trends in Cancer
a) Heatmap displaying associations of cell populations with interferon... | Download Scientific Diagram
Overexpression of type I interferon (IFN) inducible genes as captured... | Download Scientific Diagram
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | PNAS
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Baseline type I interferon (IFN) gene signature (GS) scores for... | Download Scientific Diagram
Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression - ScienceDirect
Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures - PZ Brohawn, K Streicher, B W Higgs, C Morehouse, H Liu, G Illei,
Biomolecules | Free Full-Text | Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance: Molecular Therapy - Oncolytics
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer | PNAS
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma | npj Genomic Medicine
Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures - PZ Brohawn, K Streicher, B W Higgs, C Morehouse, H Liu, G Illei,
Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses - eBioMedicine
Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus | Arthritis Research & Therapy | Full Text
Frontiers | Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase ...
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Expression of selected interferon signature genes and heat shock... | Download Scientific Diagram
Interferon Family - an overview | ScienceDirect Topics
Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus | Communications Biology
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE | Lupus Science & Medicine
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 - ScienceDirect
